Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.065
0.00 (0.00%)
After-Hours: 16:47
Opus Genetics Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.0124 |
December 31, 2021 | 0.0242 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2021
0.0242
Maximum
Dec 2021
0.0028
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
Baxter International Inc | 1.688 |
Syros Pharmaceuticals Inc | -- |
Elanco Animal Health Inc | 0.6679 |
NovaBay Pharmaceuticals Inc | -1.128 |
Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 44.83M |
Total Liabilities (Quarterly) | 4.198M |
Shareholders Equity (Quarterly) | 40.64M |
Current Ratio | 10.68 |